Tadahiro Matsumoto
Overview
Explore the profile of Tadahiro Matsumoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamazaki T, Kitahara H, Yamashita D, Sato T, Suzuki S, Hiraga T, et al.
PLoS One
. 2024 Sep;
19(9):e0309758.
PMID: 39298466
Background: It is still unclear whether body mass index (BMI) affects bleeding and cardiovascular events in patients requiring oral anticoagulants (OAC) for atrial fibrillation (AF) and antiplatelet agents after percutaneous...
2.
Yaginuma H, Saito Y, Sato T, Yamashita D, Matsumoto T, Suzuki S, et al.
PLoS One
. 2023 Aug;
18(8):e0289794.
PMID: 37616328
Background: Chronic systemic inflammatory diseases (CSIDs) such as rheumatoid arthritis (RA) are reportedly associated with an increased risk of ischemic cardiovascular events including acute myocardial infarction (MI). However, data are...
3.
Matsumoto T, Saito Y, Sato T, Yamashita D, Suzuki S, Saito K, et al.
Heart Vessels
. 2023 Aug;
39(1):1-9.
PMID: 37598361
The Japanese version of high bleeding risk (J-HBR) criteria was domestically proposed to identify patients at HBR after percutaneous coronary intervention (PCI). The applicability of J-HBR on bleeding events has...
4.
Yamashita D, Saito Y, Sato T, Matsumoto T, Suzuki S, Saito K, et al.
Intern Med
. 2023 Jun;
63(4):475-480.
PMID: 37344423
Objective The Patterns of Non-adherence to Anti-platelet Regimen in Stented Patients (PARIS) and Coronary Revascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) thrombotic and bleeding risk scores were established to predict...
5.
Kitahara H, Yamashita D, Sato T, Suzuki S, Hiraga T, Yamazaki T, et al.
J Cardiol
. 2023 Jun;
82(3):207-214.
PMID: 37336423
Background: The efficacy and safety of dual antithrombotic therapy (DAT) with oral anticoagulant and P2Y12 inhibitors (P2Y12i) in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) have not...
6.
Goto H, Saito Y, Matsumoto T, Sato T, Yamashita D, Suzuki S, et al.
J Atheroscler Thromb
. 2023 Jun;
30(12):1791-1802.
PMID: 37316266
Aims: Several scoring systems, including the ABCD-GENE and HHD-GENE scores incorporating clinical and genetic factors, have been developed to identify patients likely to have high platelet reactivity on P2Y12 inhibitors,...
7.
Matsumoto T, Kitahara H, Yamazaki T, Hiraga T, Yamashita D, Sato T, et al.
Cardiovasc Interv Ther
. 2023 May;
38(4):381-387.
PMID: 37204672
It is well known that patients with acute myocardial infarction (AMI) have delayed vessel healing despite accelerated endothelial progenitor cells (EPC) mobilization. The COMBO stent is a unique biodegradable-polymer sirolimus-eluting...
8.
Asada K, Saito Y, Sato T, Matsumoto T, Yamashita D, Suzuki S, et al.
Circ J
. 2022 Nov;
87(5):640-647.
PMID: 36418113
Background: In patients with acute myocardial infarction (AMI), elevated natriuretic peptide (NP) concentrations are reportedly associated with worse clinical outcomes. This study evaluated the prognostic value of NP concentrations and...
9.
Sato T, Saito Y, Suzuki S, Matsumoto T, Yamashita D, Saito K, et al.
Life (Basel)
. 2022 Oct;
12(10).
PMID: 36295106
Among patients with acute myocardial infarction (MI) complicated by cardiogenic shock (CS), in-hospital mortality remains high. In the present study, we aimed to identify factors associated with clinical outcomes of...
10.
Impact of Denture Use on Ischemic and Bleeding Outcomes of Patients with Acute Myocardial Infarction
Yamashita D, Saito Y, Sato T, Matsumoto T, Suzuki S, Saito K, et al.
Intern Med
. 2022 Sep;
62(9):1251-1257.
PMID: 36130888
Objective Oral diseases, including periodontitis and stomatitis, are highly prevalent worldwide and reportedly associated with the development of cardiovascular disease. Given the high rate of stomatitis in individuals wearing dentures,...